targeted immunotherapy Archives

Testing Targeted Immunotherapy Against Pancreatic Cancer

Targeted immunotherapy is the focus of a clinical trial that tests the drug ibrutinib, approved for leukemia treatment, against pancreatic cancer.

Join our community Sign up for updates from Let’s Win!

Terms & Conditions • Privacy Policy

Please note that this information is not intended to be a substitute for professional medical opinion, advice or diagnosis. We encourage you to use this information to begin a dialogue with your physician about the treatment plan that is right for you.